As we mentioned before, previous studies consistently approved that the expression of SLC2A5 was upregulated in several types of human cancers such as breast cancer, lung cancer, renal cell carcinoma and glioma. This evidence concerns the gene SLC2A5 and hereditary clear cell renal cell carcinoma.